One of the most common forms of crohn’s disease treatment is medication therapy. There are several classes of drugs that can help induce and maintain remission of symptoms.
Aminosalicylates: Drugs like mesalamine (Asacol, Pentasa) and sulfasalazine (Azulfidine) are classified as aminosalicylates. They help reduce inflammation in the digestive tract and are often used as a first-line...
SWOT Analysis
Strength: Inflammatory Bowel Disease Market has growing cases of Crohn's disease and ulcerative colitis globally. There is an increased focus on treatment innovation with ongoing research and development. Biologics and biosimilars have emerged as promising treatment options. Weakness: High costs associated with diagnosis and long term treatment of IBD poses a major challenge....
The global anti-inflammatory drugs market consists of drugs that are primarily used for treating inflammation-related diseases like arthritis, multiple sclerosis, and inflammatory bowel diseases. Some of the common anti-inflammatory drugs available are corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), biologics, interferons, and interleukin inhibitors. These drugs work by...
Market Dynamics:
The U.S. Medical Foods market is expected to witness high growth owing to increasing prevalence of metabolic disorders such as phenylketonuria (PKU), multiple sclerosis, and other rare diseases. As per National Institutes of Health (NIH), PKU afflicts around 350,000-400,000 individuals worldwide. Medical foods are especially designed to fulfill the specific nutritional...
Causes and Risk Factors
While the specific triggers that cause IBD are unknown, it is believed to develop from a combination of genetic, immunological and environmental factors. Some of the risk factors associated with developing IBD include:
- Genetics: Individuals who have a family member with IBD are at higher risk of developing it themselves. Certain genetic mutations can...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian